Cargando…

Comparison of clinical outcomes of Ibutilide-guided cardioversion and direct current synchronized cardioversion after radiofrequency ablation of persistent atrial fibrillation

BACKGROUP: Ibutilide has already been used for cardioversion of persistent atrial fibrillation (PsAF) after radiofrequency catheter ablation (RFCA). The purpose of this study was to determine the effect of Ibutilide-guided cardioversion on clinical outcomes after individualized ablation of PsAF. MET...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xing, He, Yan, Gui, Chun, Wen, Weiming, Jiang, Zhiyuan, Zhong, Guoqiang, Wu, Mingxing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658000/ https://www.ncbi.nlm.nih.gov/pubmed/38028483 http://dx.doi.org/10.3389/fcvm.2023.1141698

Ejemplares similares

Ibutilide for the Cardioversion of Paroxysmal Atrial Fibrillation during Radiofrequency Ablation of Supraventricular Tachycardias
por: Polymeropoulos, Kostas, et al.
Publicado: (2011)

Ibutilide for pharmacological cardioversion of atrial flutter
por: Magnusson, K, et al.
Publicado: (2002)

Ibutilide with magnesium for conversion of atrial fibrillation or flutter in rheumatic heart disease patients: Ibutilide with magnesium for chemical cardioversion of atrial fibrillation or flutter
por: Malviya, Amit, et al.
Publicado: (2020)

QTc Dynamics Following Cardioversion for Persistent Atrial Fibrillation
por: Younis, Arwa, et al.
Publicado: (2022)

Cardioversion of Post-Ablation Atrial Tachyarrhythmia with Ibutilide and Amiodarone: A Registry-Based Cohort Study
por: Cacioppo, Filippo, et al.
Publicado: (2022)

Body Weight Counts—Cardioversion with Vernakalant or Ibutilide at the Emergency Department
por: Lindmayr, Teresa, et al.
Publicado: (2022)

Defining the benefit: Cardioversion of persistent atrial fibrillation
por: Nedios, Sotirios, et al.
Publicado: (2021)

Periprocedural anticoagulation in atrial fibrillation: Update on electrical cardioversion and ablation
por: van Vugt, S. P. G., et al.
Publicado: (2018)

Pharmacological cardioversion for atrial fibrillation and flutter
por: Cordina, J, et al.
Publicado: (2006)

Atrial fibrillation cardioversion following acupuncture
por: Dilber, Dario, et al.
Publicado: (2015)

Rivaroxaban in atrial fibrillation cardioversion: an update
por: Lavalle, Carlo, et al.
Publicado: (2019)

How to Optimize Cardioversion of Atrial Fibrillation
por: Airaksinen, K. E. Juhani
Publicado: (2022)

A Cardioversion and Renal Dysfunction Cascade: Cardioversion for Atrial Fibrillation, Acute Kidney Injury, and Recurrence of Atrial Fibrillation
por: Asemota, Iriagbonse R, et al.
Publicado: (2020)

Impact of Additional Transthoracic Electrical Cardioversion on Cardiac Function and Atrial Fibrillation Recurrence in Patients with Persistent Atrial Fibrillation Who Underwent Radiofrequency Catheter Ablation
por: Wang, Deguo, et al.
Publicado: (2016)

Thromboembolic Events Following Atrial Fibrillation Cardioversion and Ablation: What’s the Culprit?
por: De Sensi, Francesco, et al.
Publicado: (2019)

Programmed inappropriate ICD ventricular defibrillation for cardioversion of persistent atrial fibrillation
por: Korantzopoulos, Panagiotis, et al.
Publicado: (2008)

Low efficacy of cardioversion of persistent atrial fibrillation with the implantable cardioverter-defibrillator
por: Limantoro, I., et al.
Publicado: (2013)

Current Status of Internal Cardioversion in Atrial Fibrillation
por: Plewan, Andreas, et al.
Publicado: (2002)

Ogilvie's Syndrome following Cardioversion for Atrial Fibrillation
por: Al-Halawani, Moh'd, et al.
Publicado: (2014)

Chemical Cardioversion of Atrial Fibrillation with Calcium Gluconate
por: Serhat, A, et al.
Publicado: (2012)

Timing of cardioversion in atrial fibrillation: the sooner the better?
por: Capranzano, Piera, et al.
Publicado: (2020)

Feasibility and safety of the direct current cardioversion at the time of left atrial appendage occlusion for patients with atrial fibrillation
por: Meng, Xian Sai, et al.
Publicado: (2023)

Prediction of Successful Pharmacological Cardioversion in Acute Symptomatic Atrial Fibrillation: The Successful Intravenous Cardioversion for Atrial Fibrillation (SIC-AF) Score
por: Niederdöckl, Jan Daniel, et al.
Publicado: (2022)

Defibrillation threshold of internal cardioversion prior to ablation predicts atrial fibrillation recurrence
por: Sawasaki, Kohei, et al.
Publicado: (2021)

Pharmacological Cardioversion after Pre-Treatment with Antiarrythmic Drugs Prior to Electrical Cardioversion in Persistent Atrial Fibrillation: Impact on Maintenance of Sinus Rhythm
por: El Amrani, Amine, et al.
Publicado: (2021)

Efficacy and effects on cardiac function of radiofrequency catheter ablation vs. direct current cardioversion of persistent atrial fibrillation with left ventricular systolic dysfunction
por: Wang, Maojing, et al.
Publicado: (2017)

The Role of Biphasic Shocks for Transthoracic Cardioversion of Atrial Fibrillation
por: Walsh, Simon J, et al.
Publicado: (2005)

Planning and monitoring of patients for electrical cardioversion for atrial fibrillation
por: Deuling, J. H. H., et al.
Publicado: (2011)

Comparison of monophasic versus biphasic cardioversion for atrial fibrillation
por: Vaisman, M, et al.
Publicado: (2005)

Rare Coronary Embolism Secondary to Cardioversion of Atrial Fibrillation
por: Alkhatib, Deya, et al.
Publicado: (2022)

Transesophageal Echocardiogram Before Cardioversion in Atrial Fibrillation Patients
por: Adedara, Victor O, et al.
Publicado: (2023)

The Outcome of Electrical Cardioversion in Hyperthyroid Induced Atrial Fibrillation
por: Shah, Hriday, et al.
Publicado: (2023)

Left atrial strain significance in prediction of early atrial fibrillation recurrence after cardioversion and ablation
por: Sabanovic-Bajramovic, N, et al.
Publicado: (2023)

Frequency of cardioversions as an additional risk factor for stroke in atrial fibrillation – the FinCV-4 study
por: Jaakkola, Samuli, et al.
Publicado: (2022)

Racial and Sex Disparities in Anticoagulation After Electrical Cardioversion for Atrial Fibrillation and Flutter
por: Mentias, Amgad, et al.
Publicado: (2021)

Effect of Early Pharmacologic Cardioversion vs. Non-early Cardioversion in the Patients With Recent-Onset Atrial Fibrillation Within 4-Week Follow-Up Period: A Systematic Review and Network Meta-Analysis
por: Tang, Yan, et al.
Publicado: (2022)

External Electrical Cardioversion is an Easy and Safe Intervention for Rhythm Control in Persistent Atrial Fibrillation
por: Kwon, Chang Hee
Publicado: (2020)

Effectiveness of electrical cardioversion for persistent atrial fibrillation in the ongoing protocolenergy: hawthorne effect trial
por: Jiravsky, O, et al.
Publicado: (2023)

Machine Learning Prediction for the Recurrence After Electrical Cardioversion of Patients With Persistent Atrial Fibrillation
por: Kwon, Soonil, et al.
Publicado: (2023)

Low-Dose Ibutilide Combined with Catheter Ablation of Persistent Atrial Fibrillation: Procedural Impact and Clinical Outcome
por: Sun, Xue-Rong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cu1ufjc73t5m99o8g6cpe2i7to